Robert Michael Dudley - Chief Executive Officer, Director at Transcode Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
RNAZ on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Robert Michael Dudley - trading volume in the past year for Transcode Therapeutics, Inc.

Holdings reported by Robert Michael Dudley for Transcode Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 180K $91.9K $0.51 Sep 28, 2023 Direct

Transactions reported by Robert Michael Dudley for Transcode Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.